RNA‐Binding Proteins: Function, Biological Mechanisms, and Therapeutic Opportunities
MedComm · 2026-09 · 7 (9)
DOI: 10.1002/mco2.70938 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 24.08.2026. Verfasst von Ling Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Interdisciplinary Integrative Medicine Research Shanghai University of Traditional Chinese Medicine Shanghai China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 351 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
RNA‐binding proteins (RBPs) are central regulators of post‑transcriptional gene expression, controlling RNA stability, localization, translation, and alternative splicing. Their functions arise not only from intrinsic RNA‐binding domains but also from dynamic interactions with noncoding RNAs, metabolites, cofactors, and other RBPs. Here, we summarize the structural diversity and core biological activities of canonical and noncanonical RBPs, and delineate how competitive and cooperative regulatory networks dictate RBP function in disease, with an emphasis on cancer. Competitive mechanisms, including lncRNA‐mediated sequestration, antagonistic crosstalk between miRNAs and RBPs, and competition among RBPs for shared substrates, can redirect RNA fate. In contrast, cooperative mechanisms assemble multimolecular ribonucleoprotein complexes that reinforce oncogenic or tumor‐suppressive programs. Dysregulation of these networks promotes proliferation, metastasis, immune evasion, and therapy resistance. We also review emerging therapeutic strategies that target RBP‐centered regulatory circuits, including antisense oligonucleotides, small molecules, protein degraders, and natural products, and we evaluate representative preclinical studies and clinical trials. By integrating mechanistic principles with translational evidence, this review provides a network‐based framework for exploiting RBPs as therapeutic vulnerabilities and for advancing next‐generation precision oncology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Interdisciplinary Integrative Medicine Research Shanghai University of Traditional Chinese Medicine Shanghai China.
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine Shanghai China.
- Department of Medical Oncology & Cancer Institute of Integrative Medicine Shuguang Hospital, Shanghai University of Traditional Chinese Medicine Shanghai China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, L., Yan, X., Ji, Q., & Zhang, H. (2026). RNA‐Binding Proteins: Function, Biological Mechanisms, and Therapeutic Opportunities. MedComm, 7(9). https://doi.org/10.1002/mco2.70938
Vancouver
Li L, Yan X, Ji Q, Zhang H. RNA‐Binding Proteins: Function, Biological Mechanisms, and Therapeutic Opportunities. MedComm. 2026;7(9). doi:10.1002/mco2.70938
BibTeX
@article{Li2026,
author = {Li, Ling and Yan, Xiuli and Ji, Qing and Zhang, Hui},
title = {RNA‐Binding Proteins: Function, Biological Mechanisms, and Therapeutic Opportunities},
journal = {MedComm},
year = {2026},
volume = {7},
number = {9},
doi = {10.1002/mco2.70938}
}
EUVIMED